BioXcel Therapeutics Inc.

1.63
-0.19 (-10.44%)
At close: Apr 04, 2025, 3:59 PM
1.50
-7.69%
Pre-market: Apr 07, 2025, 05:02 AM EDT

BioXcel Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for BTAI stock have an median target of 48, with a low estimate of 4 and a high estimate of 80. The median target predicts an increase of 2844.79% from the current stock price of 1.63.

Target Low Average Median High
Price $4 $42.6 $48 $80
Change 145.40% 2513.50% 2844.79% 4807.98%

Latest Analyst Insight Report

HC Wainwright & Co. maintains a Buy rating for Bio... Unlock content with Pro Subscription

Updated Jan 30, 2025

Rating Jun 24Aug 24Sep 24Oct 24Jan 25Mar 25
Strong Buy 000000
Buy 121121
Hold 010000
Sell 000010
Strong Sell 000000
Total 1 3 1 1 3 1

Financial Forecast this Year

Revenue This Year
4.85M
from 2.27M
Increased by 114.0%
Revenue Next Year
11.91M
from 4.85M
Increased by 145.7%
EPS This Year
-15.22
from -23.51
Increased by 35.3%
EPS Next Year
-15.95
from -15.22
Increased by -4.8%